Comprehensive Genomic Profiling
Comprehensive Genomic Profiling (CGP) utilizes next-generation sequencing technology to enable simultaneous detection of multiple cancer biomarkers. Currently, many sequential tests are used to assess single biomarkers for cancer diagnosis. By implementing a CGP approach, more information can be assessed from limited biopsy tissue to deliver time and cost savings. Recent years have seen growing adoption of CGP in oncology, but what are the next steps?
In this feature, we will be looking at how CGP can positively impact oncology practice and the challenges that need to be overcome. We will also be exploring how CGP can contribute to improve patient outcomes
In this episode of OCTalks, Oncology Central speaks with Professor Michael Thomas, Head of the Department of Thoracic Oncology and Internal Medicine at Thoraxklinik-Heidelberg (Germany). We discuss the adoption of CGP in oncology and Michael’s own experiences of implementing CGP into clinical practice.
Our recent In Focus has focused on Comprehensive Genomic Profiling (CGP). This infographic details the 5 take-home points for CGP, including the value of this emerging technology and the ideal content for a CGP test.